Lower dose by design*
Nothing matters more than your patients’ well being. That’s why GE Healthcare created Lower Dose by Design — to focus on innovation, patient care, and teamwork. Lower Dose by Design combines research, training, technology, and clinical practice to achieve diagnostic image quality at optimized dose. These technologies help record and monitor the dose. We are committed to helping you deliver the highest quality patient care — today and tomorrow.
Dose Check alerts you when a pre-determined dose level will be exceeded. A prompt alerts your operator to the situation. The operator can then either change the scan or override the notification. All overrides are documented, providing an audit trail for future analysis. Learn more about Dose Check by downloading these helpful documents:
Dose Check Intro Letter
Dose Check Welcome Letter
Dose Check Overview
Dose Check Frequently Asked Questions
Optidose technology adds further dose reduction capabilities along the imaging chain. It features SmartTrack* dynamic collimation to limit penumbra and helical over-scanning, 3D automatic dose modulation, ECG dose modulation, and X-ray filtration for small to large patients.
Low dose scanning historically may have raised questions related to the diagnostic quality of the resultant images. However, our industry-exclusive Adaptive Statistical Iterative Reconstruction (ASiR) may help clinicians achieve confident diagnosis with lower dose1. ASiR, the first iterative reconstruction technology, may enable reduction in pixel noise standard deviation, and its reconstruction algorithm may allow for reduced mA in the acquisition of diagnostic images, thereby reducing the dose required1. ASiR may also enable an improvement in LCD1. Combine ASiR with SnapShot Pulse* for even further dose reduction in cardiac exams.
Veo is our newest dose technology. It is the world’s first model-based, iterative reconstruction product. By combining sophisticated algorithms and advanced computing power, Veo may enable reduction in pixel noise standard deviation. The Veo reconstruction algorithm may then allow for reduced mA or kVp in the acquisition of diagnostic images, thereby reducing the dose required1. Also, Veo reconstruction may enable improvement in low contrast detectability and spatial resolution. It has the capability to reduce low signal artifacts generated by dense anatomy or metal implants compared to FBP2. This exceptional technology may allow you to achieve imaging under 1mSv with profound clarity.
1. In clinical practice, the use of ASiR and Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
2. In clinical practice, the actual level of LCD and spatial resolution improvement, and low signal artifact improvement may vary. Consult with a radiologist and a physicist.